Zylö Receives $294,000 NIH Phase I Grant to Advance its Cutaneous Lupus Program
May 31, 2023 13:00 ET
|
Zylö Therapeutics
Funds to be used to demonstrate efficacy in a new mouse model of cutaneous lupus GREENVILLE, SC, May 31, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod® topical delivery...
Zylö Receives $225,000 NIH Grant to Further Develop Nitric-Oxide-Releasing Z-pods™ to Treat Erectile Dysfunction
November 12, 2019 09:00 ET
|
Zylö Therapeutics
GREENVILLE, SC, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $225,000 Small Business Technology...